The Traderszone Network

Published in TZ Latest News 18 June, 2015 by The TZ Newswire Staff

The Reason Behind TG Therapeutics Inc.’s Soaring Stock Price

TG Therapeutics is off to the races after updating phase 2 results for one of its leading compounds. Find out what the buzz is all about, and whether you should be buying into it.